As of 2025-10-22, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is -0.07 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Revive Therapeutics Ltd is -577.80%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Revive Therapeutics Ltd (RVV.CN) is overvalued by 577.80%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.07 - -0.07 | -0.07 | -577.80% |
| DDM - Stable | (0.11) - (0.66) | (0.39) | -2675.1% |
| DDM - Multi | (0.00) - (0.01) | (0.00) | -128.2% |
| Market Cap (mil) | 6.28 |
| Beta | 4.02 |
| Outstanding shares (mil) | 418.56 |
| Enterprise Value (mil) | 6.28 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.64% |
| Cost of Debt | 5.00% |
| WACC | 7.61% |